" /> " />

Laboratory Earnings Estimate

LH Stock  USD 216.57  3.05  1.43%   
The next projected EPS of Laboratory is estimated to be 3.51 with future projections ranging from a low of 3.3 to a high of 3.67. Laboratory's most recent 12-month trailing earnings per share (EPS TTM) is at 4.33. Please be aware that the consensus of earnings estimates for Laboratory is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Laboratory is projected to generate 3.51 in earnings per share on the 31st of March 2024. Laboratory earnings estimates module stress-tests analyst consensus about projected Laboratory EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Laboratory, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Laboratory's earnings estimates, investors can diagnose different trends across Laboratory's analyst sentiment over time as well as compare current estimates against different timeframes. As of now, Laboratory's Operating Profit Margin is decreasing as compared to previous years. The Laboratory's current Net Profit Margin is estimated to increase to 0.07, while Gross Profit is projected to decrease to under 1.9 B.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.

Laboratory Earnings Estimation Breakdown

The calculation of Laboratory's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Laboratory is estimated to be 3.51 with the future projection ranging from a low of 3.3 to a high of 3.67. Please be aware that this consensus of annual earnings estimates for Laboratory is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
3.3
3.30
Lowest
Expected EPS
3.51
3.67
Highest

Laboratory Earnings Projection Consensus

Suppose the current estimates of Laboratory's value are higher than the current market price of the Laboratory stock. In this case, investors may conclude that Laboratory is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Laboratory's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2024Current EPS (TTM)
1997.11%
3.3
3.51
4.33

Laboratory Earnings History

Earnings estimate consensus by Laboratory analysts from Wall Street is used by the market to judge Laboratory's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Laboratory's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Laboratory Quarterly Gross Profit

762.2 Million

As of now, Laboratory's Retained Earnings are increasing as compared to previous years. The Laboratory's current Retained Earnings Total Equity is estimated to increase to about 12.6 B, while Price Earnings To Growth Ratio is forecasted to increase to (0.68). The Laboratory's current Common Stock Shares Outstanding is estimated to increase to about 96.2 M. The Laboratory's current Net Income Applicable To Common Shares is estimated to increase to about 1.5 B.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Laboratory's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
215.51216.69217.87
Details
Intrinsic
Valuation
LowRealHigh
194.91231.30232.48
Details
Naive
Forecast
LowNextHigh
215.04216.23217.41
Details
17 Analysts
Consensus
LowTargetHigh
222.11244.08270.93
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Laboratory. Your research has to be compared to or analyzed against Laboratory's peers to derive any actionable benefits. When done correctly, Laboratory's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Laboratory. Note that many institutional investors and large investment bankers can move markets due to the volume of Laboratory assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Laboratory. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Laboratory's stock price in the short term.

Laboratory Earnings per Share Projection vs Actual

Actual Earning per Share of Laboratory refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Laboratory predict the company's earnings will be in the future. The higher the earnings per share of Laboratory, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Laboratory Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Laboratory, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Laboratory should always be considered in relation to other companies to make a more educated investment decision.

Laboratory Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Laboratory's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-15
2023-12-313.263.30.04
2023-10-26
2023-09-303.333.380.05
2023-07-27
2023-06-303.533.80.27
2023-04-25
2023-03-313.963.82-0.14
2023-02-16
2022-12-314.14.140.04
2022-10-27
2022-09-304.674.680.01
2022-07-28
2022-06-304.74.950.25
2022-04-28
2022-03-315.986.110.13
2022-02-10
2021-12-315.86.770.9716 
2021-10-28
2021-09-304.926.821.938 
2021-07-29
2021-06-305.536.130.610 
2021-04-29
2021-03-317.438.791.3618 
2021-02-11
2020-12-318.1110.562.4530 
2020-10-27
2020-09-305.318.413.158 
2020-07-28
2020-06-3012.571.57157 
2020-04-29
2020-03-311.952.370.4221 
2020-02-13
2019-12-312.82.860.06
2019-10-24
2019-09-302.852.90.05
2019-07-25
2019-06-302.922.930.01
2019-04-30
2019-03-312.532.620.09
2019-02-07
2018-12-312.492.520.03
2018-10-24
2018-09-302.882.84-0.04
2018-07-25
2018-06-302.932.980.05
2018-04-25
2018-03-312.632.780.15
2018-02-06
2017-12-312.382.450.07
2017-10-25
2017-09-302.392.460.07
2017-07-26
2017-06-302.42.470.07
2017-04-25
2017-03-312.22.220.02
2017-02-16
2016-12-312.132.150.02
2016-10-26
2016-09-302.292.25-0.04
2016-07-27
2016-06-302.32.310.01
2016-04-25
2016-03-311.962.020.06
2016-02-18
2015-12-311.991.98-0.01
2015-10-26
2015-09-302.062.070.01
2015-07-28
2015-06-302.032.090.06
2015-04-27
2015-03-311.631.730.1
2015-02-20
2014-12-311.631.650.02
2014-10-28
2014-09-301.751.80.05
2014-07-18
2014-06-301.771.780.01
2014-04-28
2014-03-311.581.51-0.07
2014-02-07
2013-12-311.661.61-0.05
2013-10-18
2013-09-301.81.80.0
2013-07-19
2013-06-301.81.80.0
2013-04-19
2013-03-311.761.74-0.02
2013-02-08
2012-12-311.621.630.01
2012-10-18
2012-09-301.741.760.02
2012-07-19
2012-06-301.771.770.0
2012-04-19
2012-03-311.671.740.07
2012-02-10
2011-12-311.531.560.03
2011-10-20
2011-09-301.61.610.01
2011-07-21
2011-06-301.631.640.01
2011-04-21
2011-03-311.461.520.06
2011-02-10
2010-12-311.311.340.03
2010-10-21
2010-09-301.41.470.07
2010-07-22
2010-06-301.421.460.04
2010-04-21
2010-03-311.311.3-0.01
2010-02-11
2009-12-311.151.160.01
2009-10-22
2009-09-301.151.220.07
2009-07-23
2009-06-301.271.30.03
2009-04-23
2009-03-311.171.220.05
2009-02-12
2008-12-311.091.10.01
2008-10-23
2008-09-301.121.1-0.02
2008-07-24
2008-06-301.241.240.0
2008-04-24
2008-03-311.141.140.0
2008-02-07
2007-12-311.011.040.03
2007-10-25
2007-09-301.091.07-0.02
2007-07-24
2007-06-301.091.090.0
2007-04-26
2007-03-310.930.980.05
2007-02-15
2006-12-310.720.850.1318 
2006-10-24
2006-09-300.80.840.04
2006-07-25
2006-06-300.830.870.04
2006-04-25
2006-03-310.740.760.02
2006-02-16
2005-12-310.650.670.02
2005-10-20
2005-09-300.720.7-0.02
2005-07-21
2005-06-300.750.760.01
2005-04-19
2005-03-310.650.670.02
2005-02-15
2004-12-310.610.610.0
2004-10-21
2004-09-300.660.660.0
2004-07-22
2004-06-300.660.70.04
2004-04-22
2004-03-310.590.610.02
2004-02-12
2003-12-310.530.530.0
2003-10-23
2003-09-300.590.590.0
2003-07-22
2003-06-300.60.60.0
2003-04-28
2003-03-310.490.510.02
2003-02-18
2002-12-310.360.360.0
2002-10-30
2002-09-300.440.460.02
2002-07-24
2002-06-300.540.550.01
2002-04-22
2002-03-310.460.470.01
2002-02-13
2001-12-310.270.290.02
2001-10-22
2001-09-300.340.370.03
2001-07-23
2001-06-300.350.370.02
2001-04-23
2001-03-310.310.310.0
2001-02-14
2000-12-310.150.08-0.0746 
2000-10-23
2000-09-300.20.240.0420 
2000-07-19
2000-06-300.220.240.02
2000-04-24
2000-03-310.110.180.0763 
1999-10-20
1999-09-300.080.080.0
1999-07-22
1999-06-300.130.150.0215 
1999-04-22
1999-03-310.050.050.0
1999-02-23
1998-12-31-0.02-0.28-0.261300 
1998-10-27
1998-09-30-0.020.0020.022110 
1998-07-21
1998-06-30-0.040.030.07175 
1998-04-30
1998-03-31-0.1-0.020.0880 
1998-03-17
1997-12-31-0.12-0.10.0216 
1997-10-28
1997-09-30-0.07-0.12-0.0571 
1997-07-29
1997-06-300.060.05-0.0116 
1997-04-25
1997-03-310.10.05-0.0550 
1997-02-20
1996-12-3100.030.03
null
nullnullnullnull
1996-08-01
1996-06-300.320.13-0.1959 
1996-04-25
1996-03-310.190.13-0.0631 
1996-02-12
1995-12-310.380.18-0.252 
1995-10-24
1995-09-300.30.30.0

About Laboratory Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Laboratory earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Laboratory estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Laboratory fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2024
Retained Earnings7.9 B8.3 B
Retained Earnings Total Equity12 B12.6 B
Price Earnings Ratio 47.36  49.73 
Price Earnings To Growth Ratio(0.72)(0.68)

Laboratory Investors Sentiment

The influence of Laboratory's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Laboratory. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Laboratory's public news can be used to forecast risks associated with an investment in Laboratory. The trend in average sentiment can be used to explain how an investor holding Laboratory can time the market purely based on public headlines and social activities around Laboratory. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Laboratory's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Laboratory's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Laboratory's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Laboratory.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Laboratory in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Laboratory's short interest history, or implied volatility extrapolated from Laboratory options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.
Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.46)
Dividend Share
2.88
Earnings Share
4.33
Revenue Per Share
139.628
Quarterly Revenue Growth
0.035
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.